Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
2009 Standout
Functional analysis of human and chimpanzee promoters
2005 StandoutNobel
Lipoprotein lipase
2002
Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
2003
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
The genetics of ageing
2010 StandoutNature
Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
2008
Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter
2006
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
2007 Standout
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
2006 Standout
Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk
2004
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
1998
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy
2012
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet
2003
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity
2003
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
2007 Standout
Abundant Raw Material for Cis-Regulatory Evolution in Humans
2002
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
Visceral obesity attenuates the effect of the hepatic lipase −514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men
2003
Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease
1999
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders
2003
Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
1999
A review of CETP and its relation to atherosclerosis
2004
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Cholesteryl ester transfer protein and atherosclerosis
2000
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene
2000
Drug Discovery: A Historical Perspective
2000 StandoutScience
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Paraoxonase and Atherosclerosis
2001 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
2011
A Common Promoter Polymorphism in the Hepatic Lipase Gene (LIPC-480C>T) Is Associated With an Increase in Coronary Calcification in Type 1 Diabetes
2002
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Works of Gert-Jan Botma being referenced
Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor
2001
High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants
2008
A Common Mutation in the Lipoprotein Lipase Gene (N291S) Alters the Lipoprotein Phenotype and Risk for Cardiovascular Disease in Patients With Familial Hypercholesterolemia
1998
Heterogeneity at theCETPGene Locus
1997